Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
No shortage on file

EXJADE

NOVARTIS PHARMACEUTICALS CANADA INC

Quick answers

Is there a shortage of EXJADE in Canada?

No. There is no current shortage of EXJADE 500MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy
StatusNo shortage on file
Same-ingredient products on file6 products

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

EXJADE

NOVARTIS PHARMACEUTICALS CANADA INC

125MG · DIN 02287420

Different strengthSame dosage formSame routeNo current shortage

ALEMBIC-DEFERASIROX (TYPE J)

ALEMBIC PHARMACEUTICALS LIMITED

360MG · DIN 02564939

Different strengthDifferent dosage formSame routeNo current shortage

TARO-DEFERASIROX (TYPE J)

TARO PHARMACEUTICALS INC

360MG · DIN 02507331

Different strengthDifferent dosage formSame routeNo current shortage

JAMP DEFERASIROX (TYPE J)

JAMP PHARMA CORPORATION

360MG · DIN 02549859

Different strengthDifferent dosage formSame routeNo current shortage

APO-DEFERASIROX

APOTEX INC

250MG · DIN 02461552

Different strengthSame dosage formSame routeNo current shortage

APO-DEFERASIROX (TYPE J)

APOTEX INC

180MG · DIN 02485273

Different strengthDifferent dosage formSame routeNo current shortage

DIN

02287447

Strength

500MG

Dosage Form

Tablet For Suspension

Route

Oral

Active Ingredient

DEFERASIROX

See all DEFERASIROX products →

Shortage History

No shortage or discontinuation reports on file for this product.